 Melanie Rylander
Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychiatry | 3 | 2020 | 201 | 1.720 |
Why?
| | Psychotic Disorders | 2 | 2022 | 135 | 1.310 |
Why?
| | Legislation, Drug | 2 | 2020 | 78 | 1.160 |
Why?
| | Marijuana Use | 2 | 2020 | 157 | 1.090 |
Why?
| | Inpatients | 3 | 2021 | 388 | 0.970 |
Why?
| | Amphetamine-Related Disorders | 1 | 2022 | 28 | 0.860 |
Why?
| | Methamphetamine | 1 | 2022 | 51 | 0.830 |
Why?
| | Hospitalization | 3 | 2021 | 1785 | 0.800 |
Why?
| | Mental Disorders | 4 | 2020 | 939 | 0.740 |
Why?
| | Safety-net Providers | 1 | 2021 | 96 | 0.720 |
Why?
| | Education, Distance | 1 | 2019 | 36 | 0.700 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 71 | 0.690 |
Why?
| | Anorexia Nervosa | 2 | 2017 | 74 | 0.680 |
Why?
| | Physician Assistants | 1 | 2020 | 68 | 0.680 |
Why?
| | Psychiatric Department, Hospital | 2 | 2016 | 18 | 0.670 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 147 | 0.650 |
Why?
| | Program Development | 1 | 2020 | 357 | 0.620 |
Why?
| | Hospitals, Psychiatric | 1 | 2017 | 19 | 0.610 |
Why?
| | Violence | 1 | 2019 | 218 | 0.600 |
Why?
| | Binge-Eating Disorder | 1 | 2017 | 19 | 0.590 |
Why?
| | Medical Marijuana | 2 | 2020 | 102 | 0.590 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 250 | 0.590 |
Why?
| | Length of Stay | 2 | 2021 | 1032 | 0.570 |
Why?
| | Heuristics | 1 | 2015 | 9 | 0.540 |
Why?
| | Burnout, Professional | 1 | 2020 | 330 | 0.510 |
Why?
| | Medical Errors | 1 | 2015 | 89 | 0.500 |
Why?
| | Patient Readmission | 2 | 2017 | 634 | 0.470 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 162 | 0.400 |
Why?
| | Marijuana Smoking | 1 | 2014 | 220 | 0.390 |
Why?
| | Disease Progression | 1 | 2017 | 2490 | 0.350 |
Why?
| | Clinical Competence | 1 | 2015 | 951 | 0.330 |
Why?
| | Suicide | 1 | 2014 | 500 | 0.320 |
Why?
| | Comorbidity | 3 | 2020 | 1527 | 0.310 |
Why?
| | Humans | 14 | 2022 | 118972 | 0.220 |
Why?
| | Young Adult | 5 | 2020 | 10793 | 0.210 |
Why?
| | Psychotherapy, Brief | 1 | 2020 | 32 | 0.180 |
Why?
| | Education, Graduate | 1 | 2020 | 36 | 0.180 |
Why?
| | Adult | 7 | 2021 | 31512 | 0.180 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4552 | 0.180 |
Why?
| | Certification | 1 | 2020 | 99 | 0.170 |
Why?
| | Motivational Interviewing | 1 | 2020 | 84 | 0.170 |
Why?
| | Anti-Anxiety Agents | 1 | 2017 | 38 | 0.150 |
Why?
| | Adolescent | 4 | 2021 | 18480 | 0.150 |
Why?
| | Psychoses, Substance-Induced | 1 | 2016 | 14 | 0.140 |
Why?
| | Dextromethorphan | 1 | 2016 | 19 | 0.140 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 90 | 0.140 |
Why?
| | Dronabinol | 1 | 2017 | 121 | 0.140 |
Why?
| | Mental Health Services | 1 | 2020 | 331 | 0.140 |
Why?
| | Antipsychotic Agents | 1 | 2017 | 193 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2021 | 781 | 0.130 |
Why?
| | Male | 7 | 2017 | 57801 | 0.120 |
Why?
| | Problem Solving | 1 | 2015 | 145 | 0.120 |
Why?
| | Illinois | 1 | 2013 | 38 | 0.120 |
Why?
| | Quality Improvement | 1 | 2021 | 963 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 265 | 0.110 |
Why?
| | Female | 6 | 2017 | 61564 | 0.110 |
Why?
| | Odds Ratio | 1 | 2016 | 996 | 0.110 |
Why?
| | Middle Aged | 4 | 2017 | 27617 | 0.110 |
Why?
| | Vitamins | 1 | 2013 | 158 | 0.110 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1129 | 0.100 |
Why?
| | Risk Factors | 2 | 2016 | 9000 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1864 | 0.100 |
Why?
| | Suicidal Ideation | 1 | 2016 | 400 | 0.100 |
Why?
| | United States | 2 | 2020 | 12555 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2016 | 586 | 0.100 |
Why?
| | Students, Medical | 1 | 2015 | 311 | 0.100 |
Why?
| | Sex Factors | 1 | 2016 | 1781 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2017 | 12978 | 0.090 |
Why?
| | Vitamin D | 1 | 2013 | 354 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4708 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 971 | 0.080 |
Why?
| | Incidence | 1 | 2013 | 2424 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2017 | 9342 | 0.070 |
Why?
| | Colorado | 1 | 2014 | 4196 | 0.060 |
Why?
| | Prospective Studies | 1 | 2016 | 6471 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6561 | 0.050 |
Why?
| | Aged | 2 | 2015 | 19657 | 0.040 |
Why?
| | Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2016 | 2 | 0.040 |
Why?
| | Buspirone | 1 | 2016 | 5 | 0.040 |
Why?
| | Chlorpheniramine | 1 | 2016 | 10 | 0.040 |
Why?
| | Multi-Ingredient Cold, Flu, and Allergy Medications | 1 | 2016 | 4 | 0.040 |
Why?
| | Duloxetine Hydrochloride | 1 | 2016 | 9 | 0.040 |
Why?
| | Serotonin Syndrome | 1 | 2016 | 6 | 0.040 |
Why?
| | Histamine H1 Antagonists | 1 | 2016 | 33 | 0.040 |
Why?
| | Serotonin Receptor Agonists | 1 | 2016 | 28 | 0.040 |
Why?
| | Hypophosphatemia | 1 | 2015 | 21 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 362 | 0.030 |
Why?
| | Bipolar Disorder | 1 | 2016 | 209 | 0.030 |
Why?
| | Liver Diseases | 1 | 2015 | 282 | 0.030 |
Why?
| | Weight Gain | 1 | 2015 | 493 | 0.030 |
Why?
| | Hypoglycemia | 1 | 2015 | 400 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1636 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 796 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2092 | 0.020 |
Why?
|
|
Rylander's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|